Measurement of Energy Metabolism in Infants (BabyEE Pilot)

March 16, 2026 updated by: Leanne Redman, Pennington Biomedical Research Center

Measurement of Energy Metabolism in Infants: BabyEE Pilot

The purpose of this study is to measure energy expenditure during the first 3 months of life in infants.

Study Overview

Status

Recruiting

Detailed Description

This study intends to establish the feasibility of undertaking comprehensive metabolic phenotyping in infants. The overarching aim is to complete a prospective assessment of energy expenditure in the new infant metabolic chamber approximately one week apart to determine the accuracy and precision of infant protocols related to energy metabolism (sleeping metabolic rate, resting metabolic rate, diet-induced thermogenesis) and physical activity. This cross-sectional study will answer the following questions:

  1. What is the test re-test reliability of measuring energy expenditure (sleeping metabolic rate, resting metabolic rate, diet-induced thermogenesis) in an infant under the same conditions, 5-7 days apart?
  2. What is the reliability of 24h energy expenditure estimated by the infant metabolic chamber in comparison to a 7-day doubly labeled water study?
  3. How do energy expenditure measurements in infants need to be adjusted to account for variability in infant size and body composition?

Study Type

Observational

Enrollment (Estimated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Louisiana
      • Baton Rouge, Louisiana, United States, 70808
        • Recruiting
        • Pennington Biomedical Research Center
        • Principal Investigator:
          • Leanne M Redman, Ph.D.
        • Contact:
        • Sub-Investigator:
          • Eric Ravussin, Ph.D.
        • Sub-Investigator:
          • Abby Duhé Altazan, M.S.
        • Sub-Investigator:
          • Daniel Hsia, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 3 months (Child)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Full-term infants aged 1 to 3 months who are exclusively fed breast milk and/or infant formula will be recruited

Description

Inclusion Criteria:

  • Healthy, full-term infant
  • Aged 1 month (28 days) to 3 months (12 weeks, 6 days) at the first visit
  • Exclusively fed breast milk and/or infant formula
  • Willing to accept doubly-labeled water

Exclusion Criteria:

  • Unable to complete 3 clinic visits within about 14 days at Pennington Biomedical Research Center
  • Born preterm (< 37 weeks gestation)
  • Congenital abnormality or disability
  • Gastric reflux
  • Acute illness within 7 days of the study (fever, diarrhea)
  • Use of medications to treat a chronic condition (does not include use of vitamin supplements or PRN medication for flatulence or reflux such as Pepcid)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Infants
Infants aged 1-3 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Energy Expenditure by infant metabolic chamber
Time Frame: Approximately 1 week
Energy expenditure by infant metabolic chamber measured twice about 1 week apart for test re-test reliability in infants aged 1-3 months.
Approximately 1 week
Energy expenditure by doubly labeled water
Time Frame: Approximately 1 week
Energy expenditure by doubly labeled water measured over approximately 7 days in infants aged 1-3 months
Approximately 1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent body fat
Time Frame: Approximately 1 week
Percent body fat by PEA POD measured twice about 1 week apart for test re-test reliability in infants aged 1-3 months.
Approximately 1 week
Physical activity counts
Time Frame: Approximately 1 week
Physical activity counts by Actigraph accelerometer measured over approximately 7 days in infants aged 1-3 months.
Approximately 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Leanne M Redman, Ph.D., Pennington Biomedical Research Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 16, 2016

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

January 14, 2016

First Submitted That Met QC Criteria

February 10, 2016

First Posted (Estimated)

February 17, 2016

Study Record Updates

Last Update Posted (Actual)

March 18, 2026

Last Update Submitted That Met QC Criteria

March 16, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • PBRC 2015-061
  • P30DK072476-10 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant Development

Subscribe